Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Hologic's Selenia Digital Mammography System Users: Radiologists(?)

Council Members in this Study Group: 57

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

John Hewett, MD
Partner
Pacific Interventional

J. Joseph Hewett, MD is the Medical Director of Vascular Access Centers of South Los Angeles, Vascular Access Center of Los Angeles, and Newport Cancer Care Diagnostic Imaging and Interventions. He is a managing partner in Pacific Interventional which operates outpatient vascular access centers and...

Johnson Lightfoote, MD, MBA
Medical Director of Radiology
Pomona Valley Hospital Medical Center

Johnson Lightfoote, MD, MBA, is Medical Director of Radiology at Pomona Valley Hospital Medical Center and past Medical Director of University of Southern California University Hospital. His responsibilities include management of imaging services; implementation of major projects, including PACS, CT,...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

A single payer, national system does work, but may not necessarily be in the best interest of all parties.   Yes this type of system is 'free' to the users, but is funded through higher taxes than paid in the US.

Analysis of: Varian's New Rapid Arc Delivery | www.varian.com

Varian and Elekta's new arc treatments improve workflow, efficiency, and give radiation oncologists a better alternative to tomotherapy.    

October 26, 2007
Let's all exhale

This is a big hit for Pfizer - a costly product they licensed due to lack of good pipeline products.   Unfortunatley, I don't think they anticipated the issues surrounding the complexity of inhaled insulin, properly marketed the product, or did enough research on the patient side (ie compliane,...

Cardiovascular disease in breast cancer is a real risk.   As our population is aging, and breast cancer is one of the most comon cancers, it is up to us to minimize risks of treatment related morbidity.

Analysis of: Genentech to Limit Avastin Availability | online.wsj.com

While the data between avastin and lucentis is pending, it's interesting to see Genetch trying to defending profits at the expense of patients.   Genetech has impeded this trial, so that they could defend sales of Lucentis. Before lucentis was approved, avastin was used for macular degeneration...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Academic Institution*
  • Facility, Non-Academic/Community Hospital

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Director
  • Partner
  • Physician - Department Chair
  • Allied Health Professional
  • Assistant Professor
  • Physician - Resident

GLG's 850+ Clients Include:

Fortune 500®  companies
40 of the leading 50  global mutual funds
15 of the leading 20  global banks
8 of the leading 10  global private equity firms
5 of the top 10  AmLaw firms

Analytics


Generated at 2009-01-08T19:00:17.880